Sung-Hwa Yoon Selected Research

4-trifluoromethylsalicylic acid (HTB)

11/2020	2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.
1/2017	Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sung-Hwa Yoon Research Topics

Disease

9	Neuroinflammatory Diseases 11/2020 - 05/2011
5	Parkinson Disease (Parkinson's Disease) 11/2020 - 12/2011
4	Inflammation (Inflammations) 01/2019 - 05/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 01/2016
3	Infarction (Infarctions) 01/2017 - 01/2010
2	Obesity 01/2019 - 12/2009
2	Brain Injuries (Brain Injury) 01/2017 - 08/2013
1	Insulin Resistance 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Brain Infarction 01/2017
1	Stroke (Strokes) 01/2016
1	Optic Nerve Injuries 01/2016
1	Central Nervous System Diseases (CNS Diseases) 10/2015
1	Brain Ischemia (Cerebral Ischemia) 08/2013
1	Pain (Aches) 01/2013
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2010
1	Neoplasms (Cancer) 10/2010
1	Brain Neoplasms (Brain Tumor) 10/2010
1	Glioma (Gliomas) 10/2010
1	Ischemia 01/2010
1	Hemorrhagic Shock 01/2010
1	Sepsis (Septicemia) 01/2010
1	Anorexia 12/2009

Drug/Important Bio-Agent (IBA)

6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020 - 05/2011
3	Neuroprotective AgentsIBA 01/2019 - 01/2010
3	CannabinoidsIBA 01/2019 - 12/2011
2	4-trifluoromethylsalicylic acid (HTB)IBA 11/2020 - 01/2017
2	RimonabantIBA 01/2019 - 12/2009
2	CytokinesIBA 01/2019 - 06/2014
2	asaroneIBA 01/2017 - 10/2015
2	NF-kappa B (NF-kB)IBA 01/2017 - 10/2015
2	Pharmaceutical PreparationsIBA 01/2016 - 08/2013
2	EstersIBA 03/2015 - 01/2010
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2011 - 12/2009
2	Fluoxetine (Prozac)FDA LinkGeneric 05/2011 - 12/2010
1	AnhydridesIBA 11/2020
1	LipopolysaccharidesIBA 01/2020
1	Leucine-Rich Repeat ProteinsIBA 01/2019
1	NucleotidesIBA 01/2019
1	Leptin ReceptorsIBA 01/2019
1	InflammasomesIBA 01/2019
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2017
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2016
1	Therapeutic UsesIBA 10/2015
1	propionic acid (potassium propionate)IBA 03/2015
1	clovamideIBA 03/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2014
1	CD-101IBA 01/2013
1	Peptides (Polypeptides)IBA 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	LipofectamineIBA 08/2011
1	EnzymesIBA 10/2010
1	ProdrugsIBA 10/2010
1	Cytosine DeaminaseIBA 10/2010
1	Fluorouracil (Carac)FDA LinkGeneric 10/2010
1	Flucytosine (Ancobon)FDA Link 10/2010
1	Pyruvic Acid (Pyruvate)IBA 01/2010
1	ethyl pyruvateIBA 01/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2010

Therapy/Procedure

3	Intravenous Administration 01/2017 - 01/2010
1	Oral Administration 11/2020
1	Glycemic Control 01/2019
1	Therapeutics 10/2010
1	Transplantation 10/2010